CDTX
Cidara Therapeutics Inc
Halal Rating :
Last Price
$21.79
Last updated:
Market Cap
-
7D Change
2.83%
1 Year Change
2947.98%
Company Overview
Industries
Exchange
Next Earnings Date
Cidara Therapeutics Inc is a biotechnology company focused on developing novel anti-infectives. The company's lead product is rezafungin, an antifungal medication designed to treat and prevent serious fungal infections. They also have a proprietary drug-development platform called Cloudbreak, which is designed to create immunotherapy agents that couple potent targeting molecules with immune system engagers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $302000.0 | $96.29m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $8.46m | $19.15m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Cidara Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.